Doseology Sciences Inc.

MOOD

CA2584842033

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 02:38:59 2024-04-19 pm EDT			5-day change	1st Jan Change
0.36 ^CAD	0.00%		0.00%	+140.00%

2023	Doseology Sciences Inc. Announces CFO Changes	CI
2023	Doseology Sciences Inc. Announces CEO Changes	CI

Doseology Sciences Inc. Signs Distribution Agreement with Peak Performance Products Inc

April 22, 2022 at 09:00 am EDT

Doseology Sciences Inc. announced it has signed a Distribution Agreement with Peak Performance Products Inc. for the distribution of the Company's medicinal mushroom products across Canada.

Latest news about Doseology Sciences Inc.

Doseology Sciences Inc. Announces CFO Changes	23-06-30	CI
Doseology Sciences Inc. Announces CEO Changes	23-06-30	CI
Doseology Sciences Inc. Announces Board and Executive Changes	23-05-05	CI
Doseology Sciences Inc. Announces Board Changes	23-03-31	CI
Doseology Sciences Inc. Announces CEO Changes	23-03-31	CI
Doseology Sciences Inc. Announces CFO Changes	23-03-03	CI
Doseology Sciences Initiates Review Process to Explore and Evaluate Broad Range of Strategic Alternatives	23-01-24	CI
Doseology Sciences Inc. Announces Board Changes	23-01-23	CI
Doseology Sciences Inc. Goes National with Whole Foods Market	22-11-25	CI
Doseology Sciences Inc. Expands into National Retailer Sobeys Stores Across Canada	22-11-23	CI
Doseology Sciences Inc. Launches in 31 Healthy Planet Locations Across Ontario	22-10-11	CI
Doseology Sciences Inc. Announces the Introduction of Its New Brand Affiliate Program That Focuses on Digital Nomads	22-08-25	CI
Doseology Sciences Inc. Products Now Available on Retail Shelves	22-08-04	CI
Doseology Sciences Inc. Expands into US Retail Market	22-07-14	CI
Doseology Sciences Inc. Signs Distribution Agreement with Peak Performance Products Inc	22-04-22	CI
Doseology Sciences Inc. Announces CEO Changes	22-03-02	CI
Doseology Sciences Inc. Launches Health Canada NPN-Approved Medicinal Mushroom Product Line in Canada	22-02-23	CI
Doseology Announces Executive Changes	22-01-28	CI
Doseology Sciences Inc. Announces Directorate Changes	22-01-28	CI
Doseology Sciences Inc. Announces Executive Changes	22-01-13	CI
Doseology Sciences Inc. Appoints Maryam Marissen as Director	22-01-13	CI
Doseology Completes Development and Test Marketing of Adaptogenic Mushroom Product Line	22-01-06	CI
Doseology Sciences Inc. Appoints Olivier Wellman-Labadie, Ph.D. as an Advisor	21-12-15	CI

Lucy Scientific Discovery Inc., formerly Doseology Sciences Inc., is an early-stage psychedelic manufacturing company. The Company is focused on research, development and manufacturing for the emerging psychedelic-based medicine industry. The Company is advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies, medicines, and commercial products. It is engaged in developing consumer product manufacturing, marketing and distribution. The Company is dedicated to the production of a variety of natural, synthetic and biosynthetic products to meet the needs of the psychotropics-based medicine market.

Sector

Pharmaceuticals

Calendar

2024-05-26 - Q3 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DOSEOLOGY SCIENCES INC.	+140.00%	1.16M
ELI LILLY AND COMPANY	+25.83%	653B
NOVO NORDISK A/S	+27.00%	556B
JOHNSON & JOHNSON	-6.76%	354B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+3.00%	296B
ASTRAZENECA PLC	+13.09%	233B
NOVARTIS AG	+5.46%	201B
ROCHE HOLDING AG	-9.61%	193B
AMGEN INC.	-6.26%	144B

Other Pharmaceuticals